Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Seidl

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Seminars in Nuclear Medicine|March 17, 2020
Targets for Therapy of Bladder CancerChristof Seidl
Immunotherapy|May 13, 2014
Radioimmunotherapy with α-particle-emitting radionuclidesChristof Seidl
Immunotherapy|April 6, 2013
Radioimmunotherapy for peritoneal cancersChristof Seidl, Markus Essler
Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
Chromatin diminution and early cleavage in Parascaris univalens (Nematoda)Christof Seidl, Michael Bauer, Karl B Moritz
Leukemia & Lymphoma|November 3, 2020
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces <sup>18</sup>F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosisGabriel Buschner, Benedikt Feuerecker, Sabine Spinner, et al.
American Journal of Cancer Research|May 15, 2015
DCA promotes progression of neuroblastoma tumors in nude miceBenedikt Feuerecker, Christof Seidl, Sabine Pirsig, et al.
Nuclear Medicine and Biology|June 5, 2016
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologiesTimo Schwarz, Christof Seidl, Matthias Schiemann, et al.
Health Physics|September 7, 2012
Reliable and sample saving gene expression analysis approach for diagnostic tool developmentMatthias Port, Christof Seidl, Christian G Ruf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibodyStefanie Bloechl, Roswitha Beck, Christof Seidl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 11, 2006
Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cellsBarbara Stöber, Ursula Tanase, Michael Herz, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Seminars in Nuclear Medicine|March 17, 2020
Targets for Therapy of Bladder CancerChristof Seidl
Immunotherapy|May 13, 2014
Radioimmunotherapy with α-particle-emitting radionuclidesChristof Seidl
Immunotherapy|April 6, 2013
Radioimmunotherapy for peritoneal cancersChristof Seidl, Markus Essler
Roux'S Archives of Developmental Biology : the Official Organ of the EDBO|March 18, 2017
Chromatin diminution and early cleavage in Parascaris univalens (Nematoda)Christof Seidl, Michael Bauer, Karl B Moritz
Leukemia & Lymphoma|November 3, 2020
Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces <sup>18</sup>F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosisGabriel Buschner, Benedikt Feuerecker, Sabine Spinner, et al.
American Journal of Cancer Research|May 15, 2015
DCA promotes progression of neuroblastoma tumors in nude miceBenedikt Feuerecker, Christof Seidl, Sabine Pirsig, et al.
Nuclear Medicine and Biology|June 5, 2016
Increased choline uptake in macrophages and prostate cancer cells does not allow for differentiation between benign and malignant prostate pathologiesTimo Schwarz, Christof Seidl, Matthias Schiemann, et al.
Health Physics|September 7, 2012
Reliable and sample saving gene expression analysis approach for diagnostic tool developmentMatthias Port, Christof Seidl, Christian G Ruf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibodyStefanie Bloechl, Roswitha Beck, Christof Seidl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 11, 2006
Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cellsBarbara Stöber, Ursula Tanase, Michael Herz, et al.
Pageof 5